Pandora, Gap Post R...
Health Care: Health Services
Haemonetics Corporation (HAE: NYSE)
$41.08 -0.20 | -0.48%
05/24/13 - 04:01 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 41.08 |
| 52 Week High | 44.44 |
| 52 Week Low | 32.69 |
| Avg. Daily Vol. (Mil) | 0.30 |
| Beta (3 year) | 0.71 |
| Share Related Items | |
| Mkt Cap (Mil) | 2,098.23 |
| Shares Out (Mil) | 51.08 |
| Float (Mil) | 44.33 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.90 |
| Current Ratio | 3.30 |
| LT Debt/ Equity | 0.59 |
| Total Debt / Equity | 0.62 |
| Valuation Ratios | |
| Price Earnings | 55.50 |
| Price/Sales | 2.35 |
| Price/Book | 2.73 |
| Price/Cash Flow | 19.90 |
| Per Share Data | |
| Earnings | 0.74 |
| Sales | 17.46 |
| Book Value | 15.06 |
| Cash Flow | 2.06 |
| Business Summary | |
|---|---|
| Haemonetics Corporation is a healthcare company that provides blood management solutions to its customers. It serves three markets: manufacturers of plasma derived pharmaceuticals, blood collectors, and hospitals. | |
| General Information | |
| 400 Wood Road
Braintree, MA 02184 |
|
| www.haemonetics.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 3563 | |
| CEO: Brian P. Concannon | |
| Short Interest | |
| Current Month (Mil) | 3.21 |
| Previous Month (Mil) | 2.83 |
| Short Interest Ratio (Days) | 12.00 |
| Management Effectiveness | |
| Return on Equity | 5.00 |
| Return on Assets | 2.70 |
| Return on Investments | 3.20 |
| Profitability | |
| Gross Margin | 55.50 |
| EBIT Margin | 5.60 |
| Profit Margin | 4.30 |
Portfolios with HAE
- Portfolio NameUser Type
- UserGFNN Stockdiagnostics 9
- Contributor10 Health Care Stocks With ...
- UserCJ First attempt
- UserPART 1 JPMorgan 28th Annual...
- Userslparsaca Port
- UserPART 5 JPMorgan 27th Annual...
- UserLivingstonGroup Portfolio -...
- UserTest A2
- Userjmj2321 Portfolio 1
- Usermc Portfolio 1
Latest HAE Headlines from TheStreet
- Interesting HAE Put For July 05.20.13 | 02:05 pm
- HAE Crosses Above Key Moving Average Level 05.16.13 | 04:05 pm
- Haemonetics Corp. Becomes Oversold (HAE) 05.01.13 | 04:05 pm
- Haemonetics (HAE) Shares Cross Below 200 DMA 04.17.13 | 11:04 am
- 4 Stocks Hit 52-Week Highs: Kraft, Comcast 04.30.12 | 01:04 pm
- Haemonetics Stock Hits New 52-Week High (HAE) 04.30.12 | 09:04 am
- Haemonetics Stock Hits New 52-Week High (HAE) 03.26.12 | 04:03 pm
- Haemonetics Reaches New 52-Week High (HAE) 04.28.11 | 11:04 am
- Haemonetics Stock Hits New 52-Week High (HAE) 04.20.11 | 10:04 am
- Haemonetics Reaches New 52-Week High (HAE) 04.08.11 | 04:04 pm
Press Releases for HAE
- Haemonetics To Present At The Jefferies 2013 Global Healthcare Conference - PR Newswire 05.24.13 | 04:05 pm
- Haemonetics To Present At The Deutsche Bank 38th Annual DbAccess Health Care Conference - PR Newswire 05.23.13 | 04:05 pm
- Haemonetics Completes Hemerus Medical, LLC Acquisition - PR Newswire 05.01.13 | 06:05 am
- Haemonetics Sets Date For Investor/Analyst Meeting - PR Newswire 04.24.13 | 08:04 am
- Haemonetics Sets Date For Fourth Quarter Fiscal Year 2013 Earnings Release: Wednesday, May 1, 2013 - PR Newswire 04.01.13 | 04:04 pm
- Haemonetics To Present At The Raymond James Institutional Investors Conference - PR Newswire 02.25.13 | 08:02 am
- Haemonetics' CMO, Mark Popovsky, Joins U.S. Health And Human Services Advisory Committee On Blood Safety - PR Newswire 02.14.13 | 08:02 am
- Haemonetics To Present At Citi 2013 Global Healthcare Conference - PR Newswire 02.13.13 | 08:02 am
- Haemonetics To Present At Leerink Swann 2013 Global Healthcare Conference - PR Newswire 02.06.13 | 04:02 pm
- Haemonetics Sets Date For Third Quarter Fiscal Year 2013 Earnings Release: January 30, 2013 - PR Newswire 01.09.13 | 04:01 pm
Partner Headlines for HAE
- Haemonetics Beats on EPS - Analyst Blog - Zacks 10.30.12 | 09:10 am
- Mediware Completes Acquisition - Analyst Blog - NASDAQ 09.11.12 | 10:09 pm
- Mediware Completes Acquisition - Analyst Blog - Zacks 09.11.12 | 06:09 pm
- Haemonetics Remains Neutral - Analyst Blog - NASDAQ 08.16.12 | 08:08 pm
- Haemonetics Disappoints in 1Q - Analyst Blog - Zacks 08.02.12 | 09:08 am
- Pall Corporation Signs Definitive Agreement to Sell its Blood Collection, Filtration and Processing Product Lines to Haemonetics for $550M - Benzinga 04.29.12 | 12:04 pm
- Haemonetics Reaffirmed at Neutral - Analyst Blog - Zacks 03.02.12 | 06:03 pm
- Zacks Sell List Highlights: Foster Wheeler AG, ITT, Spectrum Brands Holdings and Haemonetics - Press Releases - Zacks 12.09.11 | 09:12 am
- ITT CORP (ITT) - Profit Tracks - Zacks 12.09.11 | 01:12 am
- WHIRLPOOL CORP (WHR) - Profit Tracks - Zacks 11.03.11 | 01:11 am
